West Pharmaceutical Services, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 17.47%

West Pharmaceutical Services, Inc. Return on Equity (ROE) is 17.47% for the Trailing 12 Months (TTM) ending March 31, 2025, a -14.14% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • West Pharmaceutical Services, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 20.35%, a -4.55% change year over year.
  • West Pharmaceutical Services, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 21.32%, a -30.70% change year over year.
  • West Pharmaceutical Services, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 30.77%, a 27.43% change year over year.
  • West Pharmaceutical Services, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 24.15%, a 38.90% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share